We are excited to announce that COO Juliana will be giving a keynote speech under the Health Analytics vertical on 24th of May 2019 at HIMSS Hospitalar focusing on “Digital Health – Prediction, Prevention and Precision Care”. She will share OBH’s experience in the UK and discuss the application of population segmentation and advanced analytics to measure HEALTHY LIFESPAN.. The event remains the most influential event in the Latin American healthcare segment, exhibiting over 1,200 companies and 85,000 delegates from 50 countries, discussing the latest innovations in health and care.
Whilst in Brazil, Juliana has also been invited to attend several meetings with key local stakeholders, facilitated by the DIT Brazil together with the UK Consulate in Sao Paulo. We are delighted for Juliana to have the opportunity to join another international mission, and would like to thank DIT Brazil for their ongoing support.
Nasrin Hafezparast
Co-Founder and CTO Dr Nasrin Hafezparast is co-founder and CTO at OBH. She is dual trained in both Computer Science and Medicine, both at University College London. As a fully qualified medical doctor, she has experience working as a doctor in A&E, General Practice and Hospital Medicine in London. Nasrin has an entrepreneurial background and skill set. She is a Teaching Fellow and co-leads the healthcare pathway in the MSc Technology Entrepreneurship at UCL, and is an Advisory Board member of Reform, the independent think-tank. She was selected by Management Today as one of ’35 women under 35′, and selected as one of ‘Twenty women in data & tech’ by The Female Lead and Women in Tech. She spoke at TEDxTehran on ‘Breaking through the disease barrier’. In addition, her interest in technology led her to co-found a website design and development agency in 2004 where she explored the online tech space and continues to manage a successful online B2B venture today. Nasrin brings an invaluable combination of technology and healthcare experience to OBH’s technical and process work on outcomes measurement. She has an extensive understanding and background in clinical and health datasets, and patient-reported data. Harvard Business School Value-Based Healthcare Delivery alumnus.
